Addressing Unmet Needs in Cancer Care with

Addressing Unmet Needs in Cancer Care with

About Jay PharmaNews and Insights

Jay Pharma is advancing compelling new growth opportunities within the synthetic and hemp-derived CBD sector for cancer care. Together with our partner institutions, like Tikun Olam, we hope to leverage a strong scientific and clinical view to the compounds and how they can serve to improve quality of life. To date, the use of cannabis in cancer management has been focused on symptoms management, but there is an emerging body of research that suggests CBD may have a therapeutic, anti-tumor effect on certain types of cancers.

Explore the Science of CBDCBD Combination Therapies

Opportunity

Cancer and its treatment often cause side effects – we believe that improving quality of life and supporting patients and their families is a critical part of cancer care. Jay Pharma is developing a differentiated line of novel products to improve the lives of persons suffering from cancer.

Learn More

Pipeline

Jay Pharma is advancing a pipeline of novel combination therapies as an adjunct to standard of care cancer treatments, with plans to initiate exploratory clinical studies in conditions that may include glioblastoma multiforme and radiodermatitis.

Learn More